Strategic guidance from a board-certified psychiatrist and clinical research expert who has built a top 3 nationally-ranked neuropsychiatric trial site.
Principal Investigator & Founder of IPTB Clinical Research
Dr. Jamie Winderbaum Fernandez received her undergraduate education at Emory University, graduating summa cum laude in Biology. She attended medical school at Cornell University and during that time, participated in the prestigious Howard Hughes Medical Institute (HHMI)-National Institutes of Health (NIH) Research Scholars Program.
After graduating, she completed an internship in internal medicine in New York, and residency in adult psychiatry at Stanford University Medical Center. Dr. Winderbaum Fernandez joined the University of South Florida (USF), Department of Psychiatry and Behavioral Neurosciences in 2008 where she is currently an adjunct Associate Professor, educator, and researcher.
Her past research has focused on the role of estrogen receptor signaling in Alzheimer's Disease and Postpartum Depression. Clinically, she has focused on Treatment Resistant Depression, Neurocognitive Disorders, and cutting-edge interventional therapies for neuropsychiatric illness.
She has served as the Medical Director and Chief of Inpatient Psychiatric Services at Tampa General Hospital where she established the Neurotherapies Service in 2010 and in the same roles at HCA Hospital South Tampa/West Tampa. In 2022, she started her own practice and clinical trials site, IPTB Clinical Research, to better offer Tampa Bay's diverse community her patient-centered approach to mental healthcare and provide treatment opportunities not offered elsewhere.
Adult Psychiatry
American Psychiatric Association
Tampa Bay Foundation for Mental Health
Hillsborough County Behavioral Health
Tampa Museum of Art Board of Trustees
Florida & California
Deep expertise in neuropsychiatric conditions and cutting-edge research methodologies
Extensive clinical and research experience in major depressive disorder (MDD) and treatment-resistant depression (TRD), including novel therapeutic approaches and interventional therapies.
Research background in Alzheimer's Disease including estrogen receptor signaling pathways and their role in cognitive decline and neurodegeneration.
Specialized research in postpartum depression and the role of hormonal factors in psychiatric conditions affecting women across the lifespan.
Founded and led the Neurotherapies Service at Tampa General Hospital in 2010, pioneering cutting-edge interventional approaches for neuropsychiatric conditions.
Dr. Fernandez's research career includes participation in the prestigious HHMI-NIH Research Scholars Program and ongoing work as an educator and researcher at the University of South Florida.
Strategic guidance from protocol development to site optimization—bringing real-world clinical trial expertise to your research program
Expert analysis of study protocols with recommendations to improve recruitment feasibility, retention strategies, and patient-centered design in neuropsychiatric trials.
Guidance on establishing or optimizing your clinical trial site, including team training, workflow development, and quality systems implementation.
Collaborative planning sessions to develop comprehensive study strategies, identify potential challenges, and create actionable solutions for enrollment success.
Specialized consultation on CNS trials including depression, anxiety, PTSD, cognitive disorders, and other neuropsychiatric conditions.
Review of your site's recruitment metrics, enrollment data, and operational performance with recommendations for improvement and growth.
Guidance on building strong relationships with sponsors and CROs, positioning your site for high-value studies and long-term partnerships.
Dr. Fernandez doesn't just consult—she's built IPTB Clinical Research into a top 3 nationally-ranked site. You're getting battle-tested strategies that actually work in the real world.
In 2022, Dr. Fernandez founded IPTB Clinical Research to provide Tampa Bay's diverse community with cutting-edge clinical trial opportunities and patient-centered mental healthcare.
Established independent practice and clinical trial site focused on neuropsychiatric research
Partnered with major pharmaceutical companies including Vistagen, Janssen, and Bristol-Myers Squibb
Achieved #3 national ranking for social anxiety trial recruitment through strategic enrollment strategies
Get strategic guidance from a psychiatrist who's been in the trenches and built a nationally-ranked clinical trial site from the ground up
Direct consultation sessions with Dr. Fernandez
Complete Enrollment Engine package + Dr. Fernandez consulting